-Mauro Botta Researcher Activity Profile

Research Author Detailed Information 

Mauro Botta Publication Rate By Year

Mauro Botta has published 1 paper(s) in 2002, 1 paper(s) in 2003, 1 paper(s) in 2004, 1 paper(s) in 2005, 6 paper(s) in 2006, 23 paper(s) in 2007, 9 paper(s) in 2008, for a total of 42 research publications in total.

Mauro M Botta Author Information

LAST NAME: botta

FIRST NAME: Mauro

INITIALS: m

AFFILIATION:

Papers

Mauro Botta's Publication Record

1. NMR relaxometric study of new Gd(III) macrocyclic complexes and their interaction with human serum albumin. Year Published: 2004
Dipartimento di Scienze e Tecnologie Avanzate, Corso Borsalino 54, 15100 Alessandria, Italy. mauro.botta@unito.it
2. Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents. Year Published: 2006
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
3. Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agents. Year Published: 2006
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
4. Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules. Year Published: 2006
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
5. Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity. Year Published: 2007
College of Chemistry, University of California, Berkeley, California 94720-1460, USA.
6. Optimized relaxivity and stability of [Gd(H(2,2)-1,2-HOPO)(H2O)]- for use as an MRI contrast agent. Year Published: 2007
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
7. Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Year Published: 2007
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
8. LC/ESI/MS method for the quantitative detection of guazatine residues in cereals. Year Published: 2007
9. Toward novel HIV-1 integrase binding inhibitors: molecular modeling, synthesis, and biological studies. Year Published: 2007
10. An esterase-activated magnetic resonance contrast agent. Year Published: 2007
Department of Chemistry, University Road, University of Leicester, Leicester, UK LE1 7RH.
11. Synthetic SRC-kinase domain inhibitors and their structural requirements. Year Published: 2007
12. Novel heparin/heparan sulfate mimics as inhibitors of HGF/SF-induced MET activation. Year Published: 2007
Centre for Molecular Drug Design, Cockcroft Building, University of Salford, Salford, UK.
13. 1,2-hydroxypyridonates as contrast agents for magnetic resonance imaging: TREN-1,2-HOPO. Year Published: 2007
Department of Chemistry, University of California, Berkeley, CA 94720-1460, USA.
14. Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity. Year Published: 2007
15. Antiangiogenic agents: an update on small molecule VEGFR inhibitors. Year Published: 2007
16. Identification of a novel pyrazolo[3,4-d]pyrimidine Able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice. Year Published: 2007
17. Maximizing the relaxivity of HSA-bound gadolinium complexes by simultaneous optimization of rotation and water exchange. Year Published: 2007
18. Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity. Year Published: 2007
19. Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates. Year Published: 2007
Department of Clinical Sciences, University of Rome La Sapienza, Rome, Italy.
20. Antiangiogenic agents: an update on small molecule VEGFR inhibitors. Year Published: 2007
21. Synthetic SRC-kinase domain inhibitors and their structural requirements. Year Published: 2007
22. Involvement of polyamine oxidase in wound healing. Year Published: 2008
23. Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice. Year Published: 2007
24. 1,2-hydroxypyridonates as contrast agents for magnetic resonance imaging: TREN-1,2-HOPO. Year Published: 2007
Department of Chemistry, University of California, Berkeley, CA 94720-1460, USA.
25. Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates. Year Published: 2007
Department of Clinical Sciences, University of Rome La Sapienza, Rome, Italy.
26. Structural, luminescence, and NMR studies of the reversible binding of acetate, lactate, citrate, and selected amino acids to chiral diaqua ytterbium, gadolinium, and europium complexes. Year Published: 2002
Department of Chemistry, University of Durham, South Road, UK. r.s.dickins@dur.ac.uk
27. A highly stable gadolinium complex with a fast, associative mechanism of water exchange. Year Published: 2003
Department of Chemistry, University of California, Berkeley, CA 94720, USA.
28. Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength. Year Published: 2005
Department of Chemistry, University of California-Berkeley, Berkeley, California 94720-1460, USA.
29. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Year Published: 2006
Department of Chemistry and Biochemistry, University of California-San Diego, La Jolla, CA 92093, USA.
30. Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents. Year Published: 2006
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
31. Fe(III)-templated Gd(III) self-assemblies-a new route toward macromolecular MRI contrast agents. Year Published: 2006
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
32. Microarray data analysis and mining approaches. Year Published: 2008
Department of Clinical and Biological Sciences, University of Torino, Italy. raffaele.calogero@unito.it.
33. Involvement of polyamine oxidase in wound healing. Year Published: 2008
Dipartimento di Biologia, Università Roma Tre, Viale G Marconi 446, 00146, Rome, Italy.
34. Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants. Year Published: 2007
Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via Alcide De Gasperi 2, I-53100 Siena, Italy.
35. Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Year Published: 2008
Department of Oncology, Novi Ligure Hospital, viale Giolitti, Novi Ligure (AL), Italy.
36. Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Year Published: 2008
Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Via Alcide de Gasperi 2, I-53100 Siena, Italy.
37. Maximizing the relaxivity of HSA-bound gadolinium complexes by simultaneous optimization of rotation and water exchange. Year Published: 2007
Dipartimento di Scienze dell'Ambiente e della Vita, Università del Piemonte Orientale Amedeo Avogadro, Via Bellini 25/G, I-15100 Alessandria, Italy.
38. Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM). Year Published: 2008
Department of Oncology, Novi Ligure Hospital, viale Giolitti, Novi Ligure (AL), Italy.
39. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents. Year Published: 2008
Department of Chemistry, University of California, Berkeley, California 94720-1460, USA.
40. Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Year Published: 2008
41. Involvement of polyamine oxidase in wound healing. Year Published: 2008
42. Dihydro-alkylthio-benzyl-oxopyrimidines as inhibitors of reverse transcriptase: synthesis and rationalization of the biological data on both wild-type enzyme and relevant clinical mutants. Year Published: 2007